KIAA0101 is associated with human renal cell carcinoma proliferation and migration induced by erythropoietin

Erythropoietin (EPO) is a frequently prescribed anti-anemic drug for patients with advanced renal carcinoma. However, recent evidence from clinical studies suggested that EPO accelerated tumor progression and jeopardized the 5-year survival. Herein, we show, starting from the in silico microarray bi...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Oncotarget
Huvudupphovsmän: Fan, Shengjun, Li, Xin, Tie, Lu, Pan, Yan, Li, Xuejun
Materialtyp: Artigo
Språk:Inglês
Publicerad: Impact Journals LLC 2015
Ämnen:
Research Paper
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4924658/
https://ncbi.nlm.nih.gov/pubmed/26575329
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.5876
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk